|
Name |
(2R*,4S*)-2-((1'S*)-hydroxy-4'-methylpentyl)-4-(hydroxymethyl)butanolide
|
Molecular Formula | C11H20O4 | |
IUPAC Name* |
(3R,5S)-5-(hydroxymethyl)-3-[(1S)-1-hydroxy-4-methylpentyl]oxolan-2-one
|
|
SMILES |
CC(C)CC[C@@H]([C@H]1C[C@H](OC1=O)CO)O
|
|
InChI |
InChI=1S/C11H20O4/c1-7(2)3-4-10(13)9-5-8(6-12)15-11(9)14/h7-10,12-13H,3-6H2,1-2H3/t8-,9+,10-/m0/s1
|
|
InChIKey |
OMQVQJDDMZUVNL-AEJSXWLSSA-N
|
|
Synonyms |
ZINC31158486; J3.654.467H; (2R*,4S*)-2-((1'S*)-hydroxy-4'-methylpentyl)-4-(hydroxymethyl)butanolide; (3R)-3beta-[(S)-1-Hydroxy-4-methylpentyl]-5beta-(hydroxymethyl)tetrahydrofuran-2-one
|
|
CAS | NA | |
PubChem CID | 38350557 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 216.27 | ALogp: | 1.6 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 15 | QED Weighted: | 0.676 |
Caco-2 Permeability: | -4.432 | MDCK Permeability: | 0.00039046 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.053 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.552 |
Blood-Brain-Barrier Penetration (BBB): | 0.173 | Plasma Protein Binding (PPB): | 32.67% |
Volume Distribution (VD): | 0.932 | Fu: | 56.97% |
CYP1A2-inhibitor: | 0.04 | CYP1A2-substrate: | 0.085 |
CYP2C19-inhibitor: | 0.011 | CYP2C19-substrate: | 0.381 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.603 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.122 |
CYP3A4-inhibitor: | 0.03 | CYP3A4-substrate: | 0.213 |
Clearance (CL): | 9.96 | Half-life (T1/2): | 0.692 |
hERG Blockers: | 0.026 | Human Hepatotoxicity (H-HT): | 0.416 |
Drug-inuced Liver Injury (DILI): | 0.207 | AMES Toxicity: | 0.033 |
Rat Oral Acute Toxicity: | 0.017 | Maximum Recommended Daily Dose: | 0.111 |
Skin Sensitization: | 0.628 | Carcinogencity: | 0.663 |
Eye Corrosion: | 0.175 | Eye Irritation: | 0.74 |
Respiratory Toxicity: | 0.157 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004452 | 0.316 | D0R2KF | 0.247 | ||||
ENC003648 | 0.308 | D01JQJ | 0.241 | ||||
ENC002163 | 0.292 | D07AHW | 0.224 | ||||
ENC000600 | 0.279 | D00WUF | 0.214 | ||||
ENC001221 | 0.278 | D0R6BR | 0.206 | ||||
ENC005500 | 0.277 | D0CL9S | 0.194 | ||||
ENC002575 | 0.276 | D0Z9QR | 0.188 | ||||
ENC004973 | 0.274 | D0N3NO | 0.188 | ||||
ENC004082 | 0.273 | D0C6NM | 0.187 | ||||
ENC005466 | 0.273 | D0X5XU | 0.183 |